Resistance (n = 21)

Remission (n = 28)

P

Age

Sex-ratio

Hypertension

Mean serum creatinine

Renal insufficiency

Anemia

Lymphopenia

C3 Hypocomplementemia

CH50 Hypocomplementemia

Anti-ENA

Anti-dsDNA

Mean proteinuria

Nephrotic syndrome

Microscopic hematuria

Leukocyturia

Delay between early symptomatology and start of treatment greater than 3 months

35.4 ± 7.6

8H/13F

6 cas (28.57%)

3.3 ± 2.7

12 cas (57.14%)

19 cas (90.47%)

3 cas (14.28%)

1 cas (4.76%)

1 cas (4.76%)

8 cas (38.09%)

3 cas (14.28%)

3.7 ± 2.9

11 cas (52.38%)

6 cas (28.57%)

4 cas (19.04%)

19 cas (90.47%)

31.2 ± 8.4

3H/25F

6 cas (21.42%)

2.8 ± 2.2

7 cas (25%)

24 cas (85.71%)

4 cas (14.28%)

0 cas (0%)

0 cas (0%)

12 cas (42.85%)

5 cas (17.85%)

3.4 ± 2.6

16 cas (57.14%)

12 cas (42.85%)

11 cas (39.28%)

20 cas (71.42%)

0.564

0.711

0.765

0.851

0.355

0.212

0.012

0.965

0.965

0.519

0.003

0.185

0.011

0.015

0.786

0.655